Cargando…
Good's syndrome and recurrent leishmaniasis: A case report and review of literature
We report the case of a 56-year-old Caucasian male affected by thymoma and myasthenia gravis that developed recurrent visceral leishmaniasis 11 years after thymectomy. After treatment of each relapse with liposomal amphotericin B the PCR-Leishmania was negative and the patient showed clinical improv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527582/ https://www.ncbi.nlm.nih.gov/pubmed/33024862 http://dx.doi.org/10.1016/j.heliyon.2020.e05061 |
_version_ | 1783589088637485056 |
---|---|
author | Tolomeo, Manlio Bonura, Silvia Abbott, Michelle Anastasia, Antonio Colomba, Claudia Cascio, Antonio |
author_facet | Tolomeo, Manlio Bonura, Silvia Abbott, Michelle Anastasia, Antonio Colomba, Claudia Cascio, Antonio |
author_sort | Tolomeo, Manlio |
collection | PubMed |
description | We report the case of a 56-year-old Caucasian male affected by thymoma and myasthenia gravis that developed recurrent visceral leishmaniasis 11 years after thymectomy. After treatment of each relapse with liposomal amphotericin B the PCR-Leishmania was negative and the patient showed clinical improvement. An immunologic work-up was performed showing lymphopenia with an important decrease in CD4+ T cells (52 cells/μ) and CD4/CD8 ratio (0.2). HIV test was negative. On the basis of previous thymoma and myasthenia gravis and on the basis of the immunological profile a diagnosis of Good's syndrome was made. Since IFNγ plays a main role in the control of Leishmania infection the production of IFNγ was evaluated. After mitogen stimulation of peripheral blood mononuclear cells the production of IFNγ was lower than normal. This is the second reported case of Good's syndrome with recurrent leishmaniasis and indicates that a definitive cure for leishmaniasis in patients with Good's syndrome is not possible. Immunologic work-up in our patient strongly suggests that relapses could be correlated with the low CD4+ T cell number and with the low IFNγ production. Immunotherapy with IFNγ or with compounds able to block the Th2 interleukin production could be a therapeutic option in these patients. |
format | Online Article Text |
id | pubmed-7527582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-75275822020-10-05 Good's syndrome and recurrent leishmaniasis: A case report and review of literature Tolomeo, Manlio Bonura, Silvia Abbott, Michelle Anastasia, Antonio Colomba, Claudia Cascio, Antonio Heliyon Case Report We report the case of a 56-year-old Caucasian male affected by thymoma and myasthenia gravis that developed recurrent visceral leishmaniasis 11 years after thymectomy. After treatment of each relapse with liposomal amphotericin B the PCR-Leishmania was negative and the patient showed clinical improvement. An immunologic work-up was performed showing lymphopenia with an important decrease in CD4+ T cells (52 cells/μ) and CD4/CD8 ratio (0.2). HIV test was negative. On the basis of previous thymoma and myasthenia gravis and on the basis of the immunological profile a diagnosis of Good's syndrome was made. Since IFNγ plays a main role in the control of Leishmania infection the production of IFNγ was evaluated. After mitogen stimulation of peripheral blood mononuclear cells the production of IFNγ was lower than normal. This is the second reported case of Good's syndrome with recurrent leishmaniasis and indicates that a definitive cure for leishmaniasis in patients with Good's syndrome is not possible. Immunologic work-up in our patient strongly suggests that relapses could be correlated with the low CD4+ T cell number and with the low IFNγ production. Immunotherapy with IFNγ or with compounds able to block the Th2 interleukin production could be a therapeutic option in these patients. Elsevier 2020-09-29 /pmc/articles/PMC7527582/ /pubmed/33024862 http://dx.doi.org/10.1016/j.heliyon.2020.e05061 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Tolomeo, Manlio Bonura, Silvia Abbott, Michelle Anastasia, Antonio Colomba, Claudia Cascio, Antonio Good's syndrome and recurrent leishmaniasis: A case report and review of literature |
title | Good's syndrome and recurrent leishmaniasis: A case report and review of literature |
title_full | Good's syndrome and recurrent leishmaniasis: A case report and review of literature |
title_fullStr | Good's syndrome and recurrent leishmaniasis: A case report and review of literature |
title_full_unstemmed | Good's syndrome and recurrent leishmaniasis: A case report and review of literature |
title_short | Good's syndrome and recurrent leishmaniasis: A case report and review of literature |
title_sort | good's syndrome and recurrent leishmaniasis: a case report and review of literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527582/ https://www.ncbi.nlm.nih.gov/pubmed/33024862 http://dx.doi.org/10.1016/j.heliyon.2020.e05061 |
work_keys_str_mv | AT tolomeomanlio goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature AT bonurasilvia goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature AT abbottmichelle goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature AT anastasiaantonio goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature AT colombaclaudia goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature AT cascioantonio goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature |